SCHEMBL3895326

SCHEMBL3895326

CN(C)c1ccc(N(C)c2ccc(N(C)C)cc2)cc1

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 9/20 0.79
▸ TSHR P16473 6/20 0.79
▸ ALOX15 P16050 3/20 0.79
▸ HSD17B10 Q99714 3/20 0.79
▸ MAPK1 P28482 5/20 0.58
▸ CYP3A4 P08684 3/20 0.58
▸ TDP1 Q9NUW8 3/20 0.58
▸ TP53 P04637 2/20 0.58
▸ MAPT P10636 3/20 0.50
▸ SMN1; SMN2 Q16637 2/20 0.50
▸ MEN1 O00255 1/20 0.50
▸ KMT2A Q03164 1/20 0.50
▸ SLC2A1 P11166 1/20 0.50
▸ HIF1A Q16665 1/20 0.50
▸ CHRM5 P08912 1/20 0.50
▸ CHKA P35790 1/20 0.50
▸ CYP2A6 P11509 1/20 0.50
▸ CYP2A13 Q16696 1/20 0.50
▸ HPGD P15428 1/20 0.50
▸ APP P05067 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18134996 1.00 ALDH1A1 (0.79) ALDH1A1TSHRALOX15HSD17B10MAPK1
SCHEMBL16704388 0.91 ALDH1A1 (0.65) ALDH1A1TSHRALOX15HSD17B10MAPK1
SCHEMBL15807413 0.91 ALDH1A1 (0.65) ALDH1A1TSHRALOX15HSD17B10MAPK1
SCHEMBL65261 0.89 ALDH1A1 (1.00) ALDH1A1TSHRALOX15HSD17B10MAPK1
SCHEMBL16789732 0.88 ALDH1A1 (0.83) ALDH1A1TSHRALOX15HSD17B10MAPK1
SCHEMBL17942907 0.88 ALDH1A1 (0.83) ALDH1A1TSHRALOX15HSD17B10MAPK1
SCHEMBL12258362 0.88 ALDH1A1 (0.61) ALDH1A1TSHRALOX15HSD17B10MAPK1
SCHEMBL7003328 0.86 ALDH1A1 (0.84) ALDH1A1TSHRALOX15HSD17B10MAPK1
Hydrochloric Acid SCHEMBL2443748 0.85 ALDH1A1 (0.92) ALDH1A1TSHRALOX15HSD17B10MAPK1
Hydrochloric Acid SCHEMBL379125 0.85 ALDH1A1 (0.92) ALDH1A1TSHRALOX15HSD17B10MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4752119-A Electrochromic display devices NEC CORPORATION (JP) 1988-06-21 — — US claimed
EP-4640308-A1 ENVIRONMENTALLY BIODEGRADABLE COMPOSITIONS COMPRISING AN AMINO ACID ADDUCT, CONTROLLED RELEASE PARTICLES AND COMPOSITIONS COMPRISING SAME, AND METHODS OF MAKING SAME TRuCapSol LLC (US) 2025-10-29 — — EP disclosed
US-20250326882-A1 ENVIRONMENTALLY BIODEGRADABLE COMPOSITIONS COMPRISING AN AMINO ACID ADDUCT, CONTROLLED RELEASE PARTICLES AND COMPOSITIONS COMPRISING SAME, AND METHODS OF MAKING SAME TRUCAPSOL LLC (US) 2025-10-23 — — US disclosed
US-20250326884-A1 COMPOSITIONS COMPRISING AMINO ACID ADDUCTS AND HYDROXY SILANES, CONTROLLED RELEASE PARTICLES AND COMPOSITIONS COMPRISING SAME, AND METHODS OF MAKING SAME TRUCAPSOL LLC (US) 2025-10-23 — — US disclosed
US-12187829-B2 Environmentally biodegradable microcapsules TRUCAPSOL LLC (US) 2025-01-07 — — US disclosed
US-11904288-B1 Environmentally biodegradable microcapsules TRUCAPSOL LLC (US) 2024-02-20 — — US disclosed
US-11878280-B2 Microcapsules comprising natural materials TRUCAPSOL LLC (US) 2024-01-23 — — US disclosed
EP-4265326-A2 MICROCAPSULES COMPRISING NATURAL MATERIALS TRuCapSol, LLC. (US) 2023-10-25 — — EP disclosed
US-11794161-B1 Reduced permeability microcapsules TRUCAPSOL, LLC (US) 2023-10-24 — — US disclosed
US-20230329982-A1 RESIN COMPOSITIONS COMPRISING A MACROMOLECULE CROSSLINKED WITH POLYAMIDE EPICHLOROHYDRIN, CONTROLLED RELEASE PARTICLES AND COMPOSITIONS COMPRISING SAME, AND METHODS OF MAKING SAME ALTER DOMUS (US) LLC 2023-10-19 — — US disclosed
EP-0024897-B1 CHROMOGEN SOLUTIONS AND PRESSURE-SENSITIVE MARK-RECORDING SYSTEMS MONSANTO EUROPE S.A./N.V. (BE) 1984-07-04 — — EP disclosed
EP-0005921-B1 MARK-RECORDING SYSTEMS MONSANTO EUROPE S.A./N.V. (BE) 1982-10-27 — — EP disclosed
US-4343652-A DIPHENYLMETHANOL OR DIPHENYLMETHYLAMINE DERIVATIVE, BENZYL DIESTER MONSANTO EUROPE S.A. (BE) 1982-08-10 — — US disclosed
US-4332884-A USING A DIOXIME CHELATING AGENT RICOH CO., LTD. (JP) 1982-06-01 — — US disclosed
US-4315068-A CONTAINING A COBALT-AMMINE COMPLEX AND A DIOXIME OR A BISIMIDAZOLIN-3-ONE CHELATING AGENT; STABILITY; COLOR DILMS RICOH CO., LTD. (JP) 1982-02-09 — — US disclosed
US-4306014-A AMMONIA OR AMINES SUPPRESS THE COLOR-FORMING REACTION SYSTEM RICOH CO., LTD. (JP) 1981-12-15 — — US disclosed
EP-0024897-A2 Chromogen solutions and pressure-sensitive mark-recording systems MONSANTO EUROPE S.A./N.V. (BE) 1981-03-11 — — EP disclosed
US-4251619-A Process for forming photo-polymeric image KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) 1981-02-17 — — US disclosed
EP-0005921-A1 Mark-recording systems MONSANTO EUROPE S.A./N.V. (BE) 1979-12-12 — — EP disclosed
US-4139390-A Presensitized printing plate having a print-out image EASTMAN KODAK COMPANY (US) 1979-02-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250326882-A1 ENVIRONMENTALLY BIODEGRADABLE COMPOSITIONS COMPRISING AN AMINO ACID ADDUCT, CONTROLLED RELEASE PARTICLES AND COMPOSITIONS COMPRISING SAME, AND METHODS OF MAKING SAME APEH, CD44, ATIC ALDH1A1 328/4885TSHR 4356/4885ALOX15 2903/4885
US-11878280-B2 Microcapsules comprising natural materials RCC1, SAMM50, LIPA ALDH1A1 523/4885TSHR 4027/4885ALOX15 73/4885
US-20250326884-A1 COMPOSITIONS COMPRISING AMINO ACID ADDUCTS AND HYDROXY SILANES, CONTROLLED RELEASE PARTICLES AND COMPOSITIONS COMPRISING SAME, AND METHODS OF MAKING SAME QSOX1, SSR3, CCNE2 ALDH1A1 1017/4885TSHR 3295/4885ALOX15 1326/4885
US-11794161-B1 Reduced permeability microcapsules CHMP4B, NSF, ACR ALDH1A1 4047/4885TSHR 3004/4885ALOX15 2049/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback